Colorectal cancer is the third most common cancer in the United States and is the second most common cause of cancer related death. Colorectal cancer screening tests, including colonoscopy, fecal occult blood test, and flexible sigmoidoscopy, can detect colon cancer in its early stages when it is most treatable.
This measure looks at adult patients, ages 50 to 75, who have been screened for colorectal cancer by colonoscopy, fecal occult blood test, or flexible sigmoidoscopy.
The rate at which all Partners Community practices perform this measure is 78% which is equal to the Massachusetts state average and better than the National 90th percentile.
Partners Community practices use a clinical patient registry system that identifies patients who are due for a screening. The registry provides patient lists and contact information so that practices can contact patients and help coordinate their screenings.

Partners HealthCare Data Period: January 2010 - December 2010
Partners HealthCare Source: Partners Community HealthCare, Inc.
Mass. State Average Source: Massachusetts Health Quality Partners
National 90th Percentile Source: Massachusetts Health Quality Partners

Partners HealthCare Data Period: January 2010 - December 2010
Partners HealthCare Source: Partners Community HealthCare, Inc.
Mass. State Average Source: Massachusetts Health Quality Partners
National 90th Percentile Source: Massachusetts Health Quality Partners